DETAILED NOTES ON HEMGENIX

Number of eligible patients: CDEC discussed the uncertainty in the number of patients with reasonably intense to critical hemophilia B in Canada qualified for etranacogene dezaparvovec. Medical authorities consulted by CADTH indicated that some clients that are categorized as getting mild or average disorder could possibly have a extreme bleeding p